Half of patients with type 2 diabetes do not have their disease under control Blog Post

Therapeutic compliance in type 2 diabetes mellitus (DM2) is crucial. However, only 30%-50% of patients receiving oral antidiabetics, and not even 25% of those receiving insulin adhere to their treatment regimen1. The worst compliers are younger patients who, moreover, are at greater risk of developing cardiovascular complications. This was the claim of the specialists who attended Diabento, a symposium organized by Esteve, of more than 450 physicians from all around Spain who analyzed current and future challenges in DM2 from a multidisciplinary perspective. Esteve and PCB have been working closely since 2003.